Abstract |
In this study, we investigated the antiproliferative and anti-invasive mechanism action of sodium valproate (VPA), an inhibitor of histone deacetylase (HDAC) activity, in combination with the rexinoid 6-OH-11-O-hydroxyphenanthrene (IIF), a ligand of retinoid X receptor (RXR), in the HT-29 and LoVo colon cancer cell lines. VPA inhibited HDAC-1 and increased RXRγ expression. VPA and IIF reduced viability in a dose- and time-dependent manner. The combined use of VPA and IIF enhanced the apoptosis induction. In particular, the BCL2 level decreased, while levels of BAX, cleaved caspase-3 and caspase-9 increased. The same treatment also reduced invasiveness of HT-29 cell line through the inhibition of metalloproteinase-9 (MMP9) expression, and MMP9 and MMP2 activity, with an increase of tissue inhibitors of MMPs TIMP1 and TIMP2. In conclusion, VPA and IIF have strong proapoptotic and anti-invasive effects in the HT-29 colon cancer cell line and their effects are enhanced when used together.
|
Authors | A Papi, A M Ferreri, F Guerra, M Orlandi |
Journal | Anticancer research
(Anticancer Res)
Vol. 32
Issue 7
Pg. 2855-62
(Jul 2012)
ISSN: 1791-7530 [Electronic] Greece |
PMID | 22753748
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- BAX protein, human
- Histone Deacetylase Inhibitors
- IIF compound
- Retinoid X Receptor gamma
- bcl-2-Associated X Protein
- Tretinoin
- Valproic Acid
- Caspase 3
- Caspase 9
- MMP2 protein, human
- Matrix Metalloproteinase 2
- Matrix Metalloproteinase 9
|
Topics |
- Antineoplastic Combined Chemotherapy Protocols
(pharmacology)
- Apoptosis
(drug effects)
- Caspase 3
(metabolism)
- Caspase 9
(metabolism)
- Colonic Neoplasms
(drug therapy, pathology)
- Dose-Response Relationship, Drug
- HT29 Cells
- Histone Deacetylase Inhibitors
(administration & dosage)
- Humans
- Matrix Metalloproteinase 2
(metabolism)
- Matrix Metalloproteinase 9
(metabolism)
- Neoplasm Invasiveness
- Retinoid X Receptor gamma
(metabolism)
- Tretinoin
(administration & dosage, analogs & derivatives)
- Valproic Acid
(administration & dosage)
- bcl-2-Associated X Protein
(metabolism)
|